Insider Buying: Kailera Therapeutics (NASDAQ:KLRA) Director Acquires 1,562,500 Shares of Stock

Kailera Therapeutics, Inc. (NASDAQ:KLRA) Director Adam Koppel purchased 1,562,500 shares of the firm’s stock in a transaction dated Monday, April 20th. The shares were bought at an average cost of $16.00 per share, with a total value of $25,000,000.00. Following the purchase, the director directly owned 22,583,268 shares of the company’s stock, valued at approximately $361,332,288. This represents a 7.43% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink.

Kailera Therapeutics Trading Down 5.3%

Shares of NASDAQ KLRA traded down $1.39 during trading hours on Monday, reaching $24.61. The stock had a trading volume of 1,340,343 shares. Kailera Therapeutics, Inc. has a 52-week low of $23.69 and a 52-week high of $28.23.